ZIMMER BIOMET HOLDINGS, INC. Funds and ETFs Zimmer Biomet Holdings, Inc.
Equities
ZBH
US98956P1021
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.5 USD | -0.80% |
|
+0.68% | -1.09% |
| May. 03 | Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142 | MT |
| May. 03 | UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating | MT |
ETFs positioned on Zimmer Biomet Holdings, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 0 M€ | +5.17% | ||
| 2.33% | 6 M€ | +16.84% | - | |
| 1.04% | 0 M€ | -3.76% | ||
| 0.77% | 0 M€ | +5.61% | - | |
| 0.72% | 0 M€ | +8.89% | ||
| 0.69% | 4,592 M€ | +11.18% | ||
| 0.63% | 3 M€ | +7.32% | - | |
| 0.63% | 1 M€ | +11.94% | - | |
| 0.63% | 13 M€ | -.--% | - | |
| 0.52% | 92 M€ | +0.06% | - | |
| 0.52% | 4 M€ | +20.15% | ||
| 0.42% | 0 M€ | -.--% | ||
| 0.29% | 3,859 M€ | +18.82% | - | |
| 0.29% | 469 M€ | -2.05% | - | |
| 0.27% | 9 M€ | -.--% | - | |
| 0.25% | 2 M€ | +20.44% | - | |
| 0.25% | 5 M€ | -72.95% | - | |
| 0.25% | 20 M€ | -.--% | - | |
| 0.23% | 1,006 M€ | -.--% | - | |
| 0.23% | 414 M€ | +11.37% | - | |
| 0.22% | 322 M€ | +13.88% | - | |
| 0.22% | 29 M€ | -.--% | - | |
| 0.16% | 26 M€ | +16.85% | - | |
| 0.16% | 219 M€ | +17.17% | - | |
| 0.16% | 1,448 M€ | -.--% | - | |
| 0.14% | 0 M€ | -.--% | ||
| 0.13% | 0 M€ | +8.32% | ||
| 0.13% | 0 M€ | +4.91% | - | |
| 0.12% | 330 M€ | -.--% | - | |
| 0.12% | 2 M€ | +14.69% | - | |
| 0.12% | 0 M€ | +4.68% | - | |
| 0.12% | 0 M€ | +0.87% | - | |
| 0.12% | 0 M€ | +4.68% | - | |
| 0.11% | 0 M€ | +7.87% |
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows:
- reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%);
- surgical products and traumatology equipment (22.1%);
- dental, spinal and craniomaxillofacial implants (12.8%);
- other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation.
At the end of 2021, the group had approximately 30 production sites worldwide.
Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
2024-05-10
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
121.4
USD
Average target price
136.6
USD
Spread / Average Target
+12.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.09% | 24.98B | |
| -4.77% | 185B | |
| -0.93% | 109B | |
| -3.78% | 68.54B | |
| +3.58% | 51.74B | |
| +9.25% | 45.22B | |
| +3.12% | 41.74B | |
| +4.02% | 26.83B | |
| +3.54% | 26.69B | |
| +11.62% | 25.63B |
- Stock Market
- Equities
- ZBH Stock
- Funds and ETFs Zimmer Biomet Holdings, Inc.